Literature DB >> 30593246

[Effects of Sagacious Confucius' Pillow Elixir on cognitive function in type 2 diabetic rats].

Zhi-Tao Hou1, Yu-Sheng Han1, Yi-Tian Liu2, Yu Xing1, Meng Wang1, Jing Chen1.   

Abstract

Type 2 diabetes mellitus (T2DM) is the leading threat to human health in China, and severe cognitive impairment often occurs in most T2DM patients. Although Sagacious Confucius' Pillow Elixir is a type of classical traditional Chinese medicine for cognitive impairment in clinic, the mechanism has not yet been completely defined. In this study, an experimental model of type 2 diabetes mellitus (T2DM) was established by injecting Sprague Dawley (SD) rats with streptozocin (STZ), so as to compare the learning and memory ability, hippocampal neurons pathological changes, beta amyloid protein (A beta) content, degree of Tau protein phosphorylation, blood glucose and insulin level. The results showed that the Sagacious Confucius' Pillow Elixir could improve the learning and memory ability of STZ injected rats, reduce the level of A beta content both in hippocampus and serum, effectively reduce Tau protein phosphorylation degree, and also significantly alleviate hippocampal pathological injury, blood glucose, insulin and other basic indicators. The results showed that Sagacious Confucius' Pillow Elixir can alleviate the hippocampal pathological damage caused by STZ, and is expected to provide a theoretical basis for human T2DM patients in clinical adjuvant therapy. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  Pillow Elixir ; Sagacious Confucius' ; cognitive impairment ; mechanism ; type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30593246     DOI: 10.19540/j.cnki.cjcmm.20180724.005

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Beneficial Effects of Sagacious Confucius' Pillow Elixir on Cognitive Function in Senescence-Accelerated P8 Mice (SAMP8) via the NLRP3/Caspase-1 Pathway.

Authors:  Zhitao Hou; Fengjin Li; Jing Chen; Yitian Liu; Changyuan He; Meng Wang; Tingting Mei; Yue Zhang; Liying Song; Xianming Shao
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-06       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.